GlassScriptPhysician profile
George L Restea
NPI 1881664951
$5,074.27
in general payments reported to CMS, 2019-2025
41 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $866 · 2021: $791 · 2022: $762 · 2023: $619 · 2024: $593 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,232.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $948.52 | 2021-2025 | |
| Lilly USA, LLC | $522.30 | 2020-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $491.31 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $419.40 | 2023-2025 | |
| Glaxosmithkline, LLC. | $287.27 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $267.94 | 2019-2024 | |
| Idorsia Pharmaceuticals US INC | $237.60 | 2022-2025 | Quviviq, Quviviq |
| Astrazeneca Pharmaceuticals LP | $217.04 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Baxter Healthcare | $207.97 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.45 | 2019-2022 | |
| Sk Life Science, INC. | $123.87 | 2021 | |
| Corcept Therapeutics | $89.65 | 2023-2024 | Korlym |
| Janssen Pharmaceuticals, INC | $87.99 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $84.97 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.58 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Restea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.